Just for the Schering Saphris Team

Quote

hayley williams

Guest
The day Fred Hassan strutted his way to the front of the stage to address the newly appointed "best of the best" Neuroscience Sales Team was absolutely priceless. He was late of course and most of us were starved since we had to rearrange our dinner schedule.

He told us about how he was at some gala with none other than Steve Nissen, "MD". Then came the pause. Then came the quiet rumblings. Finally, an overwhelming "BOOOO!!" emanated from every nook and cranny in that auditorium. At that point, I felt like a true salesman. Fuck my competition and screw the guy who fucked GSK (our Levitra counterparts and Asmanex foes) and Zetia. Kastelein's ENHANCE study really put some lead in our sweaters and forced us to act like our useless Merck counterparts.

Keep your heads up guys. The job market isn't that bad. Trust me.
 






hayley williams said:
The day Fred Hassan strutted his way to the front of the stage to address the newly appointed "best of the best" Neuroscience Sales Team was absolutely priceless. He was late of course and most of us were starved since we had to rearrange our dinner schedule.

He told us about how he was at some gala with none other than Steve Nissen, "MD". Then came the pause. Then came the quiet rumblings. Finally, an overwhelming "BOOOO!!" emanated from every nook and cranny in that auditorium. At that point, I felt like a true salesman. Fuck my competition and screw the guy who fucked GSK (our Levitra counterparts and Asmanex foes) and Zetia. Kastelein's ENHANCE study really put some lead in our sweaters and forced us to act like our useless Merck counterparts.

Keep your heads up guys. The job market isn't that bad. Trust me.
Click to expand...

First of all look at the big time job hoping Pharma looser political appointee Frank Amato who was given the job to run that mess. Take a closer look at the bone smuggler Mike Meehan who with a team a misfits from the Organon side sales training who launched that dog drug. To many people with no idea of what thet were doing and still don't. All moved on to new jobs to hide their lack of knowledge talent or shill sets other then ass kissing
 






Anonymous said:
First of all look at the big time job hoping Pharma looser political appointee Frank Amato who was given the job to run that mess. Take a closer look at the bone smuggler Mike Meehan who with a team a misfits from the Organon side sales training who launched that dog drug. To many people with no idea of what thet were doing and still don't. All moved on to new jobs to hide their lack of knowledge talent or shill sets other then ass kissing
Click to expand...

I mean really fire them all. They don't even cover their high overhead as former SP "TOP PERFORMERS" Boy did you guys really buy that? It was all about saving hand picked jobs!
 






Anonymous said:
First of all look at the big time job hoping Pharma looser political appointee Frank Amato who was given the job to run that mess. Take a closer look at the bone smuggler Mike Meehan who with a team a misfits from the Organon side sales training who launched that dog drug. To many people with no idea of what thet were doing and still don't. All moved on to new jobs to hide their lack of knowledge talent or shill sets other then ass kissing
Click to expand...

frank wasn't bad, but jim hassel is totally useless. he'd provide greater motivation and direction if he was found dead and rotten in home office or buckeye-ville.

mike meehan - was he a ccg rep? anyway, don't you fools know that sales training is just a meaningless dm training ground/hazing zone? its not that people don't know what they're doing its just that they are too afraid to speak up for themselves and the dm's keep telling the reps the wrong things. that's what this hapless job does to perfectly good human beings.

aah - the weather is perfect here in new jersey.
 






























How is Saphris performing? I used to know some other reps that sold it but they have since left. I have heard that there will be many generics in that class soon so whatever Sapohris does it better do it soon. What is the market share? What is the goal for the year?
 






Anonymous said:
How is Saphris performing? I used to know some other reps that sold it but they have since left. I have heard that there will be many generics in that class soon so whatever Sapohris does it better do it soon. What is the market share? What is the goal for the year?
Click to expand...
The goal should be drop the drug to a contract sales force and fire that team of loosers from the VP down. Really Frank this is the best you can do with a sales team? Oh I forgot you really never had to perform anyway there was always someone there to cover your shit
 












hey poster #9,

generics already rule the market, more coming soon.

market share is about 1% last I checked.

It costs more to deploy the reps, managers, support the so called marketing group, samples accountability relative to Saphris than they bring in from sales.

Still giving away more samples than Rx's written/pills sold..
 
























Anonymous said:
Any word of new indications?
Click to expand...

Saphris is pursuing a new indication for the drastic reduction of adult human employment due to the tardiness of molecule availability and similar price relative to eight 2nd generation antipsychotics previously available.

Several published reviews indicate that the similar efficacy, incremental metabolic benefit, BID dosing, and novel route of administration are not a sufficiently compelling reason to preferentially prescribe, as the market leader will be available generically in Q3 2011.

Further market research by Merck's market research team demonstrates a significant lack of neuropsychiatric market understanding, thereby exacerbating and accelerating the drastic reduction of adult human employment.

Merck will launch this indication very soon, I'm afraid.
 


















Anonymous said:
Saphris is pursuing a new indication for the drastic reduction of adult human employment due to the tardiness of molecule availability and similar price relative to eight 2nd generation antipsychotics previously available.

Several published reviews indicate that the similar efficacy, incremental metabolic benefit, BID dosing, and novel route of administration are not a sufficiently compelling reason to preferentially prescribe, as the market leader will be available generically in Q3 2011.

Further market research by Merck's market research team demonstrates a significant lack of neuropsychiatric market understanding, thereby exacerbating and accelerating the drastic reduction of adult human employment.

Merck will launch this indication very soon, I'm afraid.
Click to expand...

BLACK BOX WARNING

Any molecular development at Merck that leads to FDA approval is contraindicated due to the absolute risk that Merck will be solely focused on psychosocial and political appearance during launch and marketing. Such molecule will launch with only meager scientific support and post marketing surveillance activities will indicate that any mention of significant benefit to human health, health system value, or federal monetary expense reduction is contrary to the political vicissitudes of the osteoblastically challenged spines of overpaid, expedient, epidermally-challenged, and egocentric Stepford headquarters staff.

DOSAGE AND ADMINISTRATION

During launch, after a meal and at least 14oz of ethanol, insert six sealed .44 caliber doses into delivery chamber. Position delivery device distal to the ankle just behind either metatarsal region. Position index finger over delivery button and exert at least 4lbs of pressure against delivery button until sealed dose exits delivery system and enters the distal ankle region. Repeat no more than 4 doses. If 5 doses are delivered with no understanding of the gravity of the intellectually and vocationally challenged Stepford headquarters staff, insert exit end of delivery device into the sublingual area of the mouth, pointed toward the occipital area of the head, and repeat delivery process for sixth and final indicated dose. Note: After final dose, carbon unit will descend at 9.8 meters per second squared until it reaches an immovable barrier.
 












Top Bottom
Back
Quote